Janssen Pharmaceutica

...traffic they fear the new bridge will bring. "As suspected, this report centers around the importance of accommodating the expansion plans of Janssen Pharmaceutica and their anticipated (expansion) that will, in due course, result in...

In this article: Department of Environmental Protection, Anne Milgram, and Mercer County

...Hazuda dreamed of a career that would help people. Her father was an engineer. Her mother worked in the regulatory-compliance division of Janssen Pharmaceutica, now part of Johnson & Johnson. Hazuda's parents urged her to be a lawyer or...

In this article: HIV, Isentress, Merck & Co., AIDS, Integrase, Dog, and U.S. Food and Drug Administration

...and other residents who oppose the bridge plans pointed to a $10,000 contribution to by Johnson & Johnson, the parent corporation of Janssen Pharmaceuticals, which is near the bridge and would likely benefit from easing truck traffic to...

In this article: Trenton, Mercer, Anne Milgram, and Bonnie Watson Coleman

...on Rendell, with critics saying he engaged in "pay-to-play" politics. Yesterday's hearing has roots in a Pennsylvania lawsuit against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, over its antipsychotic drug Risperdal.

In this article: Pennsylvania, Risperdal, Johnson & Johnson, Henry McMaster, and Legal age

...that must be paid back by October 31, 2012. The notes are secured by $155 million in milestone payments Vertex is eligible to receive from Janssen Pharmaceutica for the European commercialization of telaprevir. In the second transaction, the...

In this article: Vertex, Telaprevir, Europe, Hepatitis C, Vertex Pharmaceuticals, Hepatitis, FDA, and Johnson & Johnson

...now." Speakers at the conference include Belgian Economic Minister Vincent Van Quickenborne, well-know diamond merchant Baron Dilip Mehta, Janssen Pharmaceutica chairman Baron Ajit Shetty, member of European parliament Nirj Deva and many...

In this article: European Union, India, Brussels, and Yves Leterme

...a portion of Holland's Crucell as part of a deal to develop flu vaccines and antibodies. Under the deal, Crucell and J&J's Ortho-McNeil-Janssen Pharmaceuticals will share responsibilities to develop a universal flu-mAb product targeting all...

In this article: Crucell, Johnson & Johnson, Wyeth, Pfizer, Cash flow, Alzheimer's, Janssen Pharmaceuticals, Ortho-McNeil, and Royal Bank of Scotland

...platforms of Crucell and the broad scientific and development expertise of Ortho-McNeil-Janssen Pharmaceuticals and its affiliates. Ortho-McNeil-Janssen Pharmaceuticals will hold commercialization rights for products resulting from...

In this article: Influenza, Johnson & Johnson, Ortho-McNeil, Crucell, Monoclonal antibodies, NIH, and Fiscal year

...with a royalty-based portfolio of products and product candidates that includes agreements with Amgen, GlaxoSmithKline, Kyowa Kirin, Nycomed, and Ortho-McNeil-Janssen Pharmaceuticals. Additional information is available at http://www.npsp.com.

In this article: Hormone, Mucositis, Short bowel syndrome, Nycomed, Janssen Pharmaceuticals, Ortho-McNeil Pharmaceuticals, Amgen, Nasdaq, and GlaxoSmithKline Pharmaceuticals

...Pharmaceutical Corporation. Prior to joining Novartis, Mr. Costa worked at Johnson & Johnson for 30 years, where he served as President of Janssen Pharmaceutica, Executive Vice President, Global Franchise Development, and was a member of...

In this article: Amylin, Amylin Pharmaceuticals, Exenatide, Obesity, Johnson & Johnson, Pramlintide, Acetate, and Nasdaq